<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Hansa Biopharma nærmer vigtig afgørelse]]></title><description><![CDATA[<p dir="auto"><a href="https://lifescience.ugebrev.dk/selskabsanalyser/ema-afgorelsen-naermer-sig-for-hansa-biopharma/" rel="nofollow ugc">https://lifescience.ugebrev.dk/selskabsanalyser/ema-afgorelsen-naermer-sig-for-hansa-biopharma/</a></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/441444/hansa-biopharma-nrmer-vigtig-afgrelse</link><generator>RSS for Node</generator><lastBuildDate>Fri, 10 Jul 2026 12:42:31 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/441444.rss" rel="self" type="application/rss+xml"/><pubDate>Fri, 12 Jun 2020 16:44:29 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Hansa Biopharma nærmer vigtig afgørelse on Sat, 13 Jun 2020 05:21:30 GMT]]></title><description><![CDATA[<p dir="auto">Låst artikel.. øv</p>
<p dir="auto">Men jeg kan jo godt regne ud at den vil styrtdykke hvis ikke det bliver godkendt.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/9459915</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/9459915</guid><dc:creator><![CDATA[koden]]></dc:creator><pubDate>Sat, 13 Jun 2020 05:21:30 GMT</pubDate></item></channel></rss>